Repare Therapeutics Inc.

CIK 1808158 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Repare Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
May 14, 2026SCHEDULE 13G/A0001140361-26-021326
Feb 19, 202615-12G0001193125-26-057875
Jan 30, 2026EFFECT9999999995-26-000362
Jan 30, 202640000921895-26-000173
Jan 30, 2026SCHEDULE 13D/A0000921895-26-000172
Jan 28, 202640002065621-26-000002
Jan 28, 2026S-8 POS0001193125-26-027437
Jan 28, 202640001815428-26-000002
Jan 28, 2026POS AM0001193125-26-027404
Jan 28, 2026S-8 POS0001193125-26-027423
Jan 28, 20268-K0001193125-26-027394
Jan 28, 2026S-8 POS0001193125-26-027436
Jan 28, 2026S-8 POS0001193125-26-027420
Jan 28, 2026S-8 POS0001193125-26-027427
Jan 28, 2026S-8 POS0001193125-26-027428
Jan 28, 202640001272181-26-000002
Jan 28, 2026S-8 POS0001193125-26-027432
Jan 28, 2026S-8 POS0001193125-26-027431
Jan 28, 202625-NSE0001354457-26-000100
Jan 28, 202640001723092-26-000002
Jan 28, 202640001250252-26-000002
Jan 27, 2026SCHEDULE 13G0001723643-26-000001
Jan 16, 20268-K0001193125-26-015507
Dec 29, 2025DEFA14A0001193125-25-332240
Dec 29, 20258-K0001193125-25-332236